PI
Research Group
Deguang Liang
liangdeguang(at)cimrbj.ac.cn
Assistant Investigator
Phospholipid Metabolism, Ferroptosis, Tumor,
Metabolic Diseases, Neurodegenerative Diseases
Scan to Learn More
Scan to Learn More
B.S. in Pharmaceutical Sciences, Sun Yet-Sen University, USA
Ph.D. in Microbiology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, China
Work Experience
2024.3-Present
Assistant Investigator, Chinese Institute for Cancer Research, Chinese Institutes for Medical Research, Beijing, China
2017.11-2024.2
Senior Scientist, Memorial Sloan Kettering Cancer Center, USA
2015.11-2017.10
Postdoctoral Scientist, Columbia University Medical Center, USA
2015.1-2015.10
Postdoctoral Scholar, Weill Cornel Medical Center, USA
2011.8-2014.12
Assistant/Associate Research Scientist, Institut Pasteur of Shanghai, Chinese Academy of Sciences, China
Research Interests
Research Interests

The Liang Laboratory is dedicated to studying the molecular regulatory mechanisms of cellular phospholipid metabolism and its functional roles in physiology and disease. Liang Lab focuses on key processes including phospholipid synthesis, remodeling, and transport, and how these processes collectively shape membrane phospholipid composition and influence cellular functions. Liang Lab is particularly interested in how phospholipid metabolism contributes to membrane lipid homeostasis and regulates susceptibility to ferroptosis. Liang Lab's goal is to understand how phospholipid metabolic networks maintain a dynamic balance between normal cellular function and protection against lipid peroxidation–induced damage, and to explore their roles in cancer, neurodegenerative disorders, and metabolic diseases. Ultimately, Liang Lab aims to identify new therapeutic targets for disease intervention. To address these fundamental questions, Liang Lab focuses on the following research areas:

• Molecular basis of phospholipid metabolic state sensing and feedback regulation

• Molecular and metabolic mechanisms linking phospholipid metabolism to ferroptosis

• Functional roles and mechanisms of phospholipid metabolic reprogramming in tumor initiation and progression

• Molecular mechanisms by which dysregulated phospholipid metabolism contributes to metabolic and neurodegenerative diseases

• Therapeutic strategies targeting phospholipid metabolic pathways 

Major Contributions
1. Identifying MBOAT1/MBOAT2 as novel ferroptosis suppressors via phospholipid remodeling process in an ER/AR regulated manner (Liang et al., Cell, 2023)
2. Identifyinga transcription factor as novel ferroptosis regulator in a tissue specific manner (paper in preparation)
Representative Publications     *:Co-first author; #:Co-corresponding author
Representative Publications *:Co-first author; #:Co-corresponding author

Liang D# and Jiang X#Redundant or resilient? A systems view of ferroptosis surveillance mechanismsCell Chem Biol., 2026 Jan 6:S2451-9456(25)00393-9. DOI: 10.1016/j.chembiol.2025.11.013

Liu X, Zhao Z, Bian Z, Benthani FA, Hu Y, Liang D#, Jiang X#Endocytosis is essential for cysteine-deprivation- induced ferroptosisMolecular Cell., 2025, 85: 3333-3342. DOI: 10.1016/j.molcel.2025.08.006

Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, Cai Y, Gu W, Stockwell B R, and Jiang X. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormonesCell, 2023, 186: 2748-64.e22. DOI: 10.1016/j.cell.2023.05.003

Liang D, Minikes A M, and Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signalingMolecular Cell, 2022, 82: 2215-2227. DOI: 10.1016/j.molcel.2022.03.022

Liang D*, Hu H*, Li S, Dong J, Wang X, Wang Y, He L, He Z, Gao Y, Gao S J, and Lan K. Oncogenic herpesvirus KSHV Hijacks BMP-Smad1-Id signaling to promote tumorigenesisPLoS Pathogens, 2014, 10: e1004253. DOI: 10.1371/journal.ppat.1004253. (* equal contribution)

Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng Q, and Lan K. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKεCell Research, 2011, 21: 793-806. DOI: 10.1038/cr.2011.5
Full List of Publications Can Be Found Here